A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ingrid U. Scott, M.D., M.P.H.
Penn State College of Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Loma Linda University Health Care, Dept. of Ophthalmology
Loma Linda, California, United States
- Southern California Desert Retina Consultants, Mc
Palm Springs, California, United States
- California Retina Consultants
Santa Barbara, California, United States
- Bay Area Retina Associates
Walnut Creek, California, United States
- Retina Vitreous Consultants
Fort Lauderdale, Florida, United States
- Central Florida Retina Institute
Lakeland, Florida, United States
- Southeast Retina Center, P.C.
Augusta, Georgia, United States
- Illinois Retina Associates
Joliet, Illinois, United States
- Raj K. Maturi, M.D., P.C.
Indianapolis, Indiana, United States
- American Eye Institute
New Albany, Indiana, United States
- Retina and Vitreous Associates of Kentucky
Lexington, Kentucky, United States
- Paducah Retinal Center
Paducah, Kentucky, United States
- Maine Vitreoretinal Consultants
Bangor, Maine, United States
- Elman Retina Group, P.A.
Baltimore, Maryland, United States
- Retina Consultants of Delmarva, P.A.
Salisbury, Maryland, United States
- Joslin Diabetes Center
Boston, Massachusetts, United States
- Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
- Retina Center, Pa
Minneapolis, Minnesota, United States
- Charlotte Eye, Ear, Nose and Throat Assoc., Pa
Charlotte, North Carolina, United States
- Wake Forest University Eye Center
Winston-Salem, North Carolina, United States
- Retina Associates of Cleveland, Inc.
Beachwood, Ohio, United States
- Casey Eye Institute
Portland, Oregon, United States
- Retina Northwest, Pc
Portland, Oregon, United States
- Penn State College of Medicine
Hershey, Pennsylvania, United States
- Retina Consultants
Providence, Rhode Island, United States
- Carolina Retina Center
Columbia, South Carolina, United States
- Palmetto Retina Center
Columbia, South Carolina, United States
- Southeastern Retina Associates, P.C.
Knoxville, Tennessee, United States
- West Texas Retina Consultants P.A.
Abilene, Texas, United States
- Retina Research Center
Austin, Texas, United States
- Texas Retina Associates
Dallas, Texas, United States
- Charles A. Garcia, Pa & Associates
Houston, Texas, United States
- Texas Retina Associates
Lubbock, Texas, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2006
- Primary completion
- 30 Nov 2006
- Completion
- 29 Feb 2008
- Last update posted
- 26 Aug 2016
- Registered enrollment
- 121
- Registry id
- NCT00336323
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.